| pubmed-article:6310893 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:6310893 | lifeskim:mentions | umls-concept:C0042216 | lld:lifeskim |
| pubmed-article:6310893 | lifeskim:mentions | umls-concept:C0020967 | lld:lifeskim |
| pubmed-article:6310893 | lifeskim:mentions | umls-concept:C0178539 | lld:lifeskim |
| pubmed-article:6310893 | lifeskim:mentions | umls-concept:C1522240 | lld:lifeskim |
| pubmed-article:6310893 | lifeskim:mentions | umls-concept:C0205263 | lld:lifeskim |
| pubmed-article:6310893 | lifeskim:mentions | umls-concept:C0750729 | lld:lifeskim |
| pubmed-article:6310893 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:6310893 | pubmed:dateCreated | 1983-10-8 | lld:pubmed |
| pubmed-article:6310893 | pubmed:abstractText | Under conditions of immunosuppression of B- and T- cell function by cyclophosphane the vaccination process in mice immunized with vaccinia virus was considerably more severe than in the untreated animals: mortality in immunosuppressed mice was much higher than in the controls; the virus could be isolated from their lungs for longer periods and in higher titres; the number of antibody-producing cells in the spleen and antibody levels in the blood were lower. In contrast to the inactivated vaccine, live vaccine itself exerted a marked immunosuppressive effect. | lld:pubmed |
| pubmed-article:6310893 | pubmed:language | rus | lld:pubmed |
| pubmed-article:6310893 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6310893 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:6310893 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6310893 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6310893 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:6310893 | pubmed:issn | 0507-4088 | lld:pubmed |
| pubmed-article:6310893 | pubmed:author | pubmed-author:GurvichE BEB | lld:pubmed |
| pubmed-article:6310893 | pubmed:author | pubmed-author:DzagurovS GSG | lld:pubmed |
| pubmed-article:6310893 | pubmed:author | pubmed-author:BerdinskikhM... | lld:pubmed |
| pubmed-article:6310893 | pubmed:author | pubmed-author:DaniliukO SOS | lld:pubmed |
| pubmed-article:6310893 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:6310893 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:6310893 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:6310893 | pubmed:pagination | 322-5 | lld:pubmed |
| pubmed-article:6310893 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:6310893 | pubmed:meshHeading | pubmed-meshheading:6310893-... | lld:pubmed |
| pubmed-article:6310893 | pubmed:meshHeading | pubmed-meshheading:6310893-... | lld:pubmed |
| pubmed-article:6310893 | pubmed:meshHeading | pubmed-meshheading:6310893-... | lld:pubmed |
| pubmed-article:6310893 | pubmed:meshHeading | pubmed-meshheading:6310893-... | lld:pubmed |
| pubmed-article:6310893 | pubmed:meshHeading | pubmed-meshheading:6310893-... | lld:pubmed |
| pubmed-article:6310893 | pubmed:meshHeading | pubmed-meshheading:6310893-... | lld:pubmed |
| pubmed-article:6310893 | pubmed:meshHeading | pubmed-meshheading:6310893-... | lld:pubmed |
| pubmed-article:6310893 | pubmed:meshHeading | pubmed-meshheading:6310893-... | lld:pubmed |
| pubmed-article:6310893 | pubmed:meshHeading | pubmed-meshheading:6310893-... | lld:pubmed |
| pubmed-article:6310893 | pubmed:meshHeading | pubmed-meshheading:6310893-... | lld:pubmed |
| pubmed-article:6310893 | pubmed:meshHeading | pubmed-meshheading:6310893-... | lld:pubmed |
| pubmed-article:6310893 | pubmed:articleTitle | [Course of the vaccinal process induced by the vaccinia virus in cyclophosphane-suppressed cellular and humoral immunity]. | lld:pubmed |
| pubmed-article:6310893 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:6310893 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:6310893 | pubmed:publicationType | English Abstract | lld:pubmed |
